by Christina U. Lorentz, Norah G

Slides:



Advertisements
Similar presentations
Journal of Molecular and Cellular Cardiology
Advertisements

Fig. 2. Post-treatment with isoflurane reduced infarct volume
An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth by Toshihiko Tanno, Peng Zhang,
Vascular Endothelial–Cadherin Tyrosine Phosphorylation in Angiogenic and Quiescent Adult Tissues by Nathalie Lambeng, Yann Wallez, Christine Rampon, Francine.
Intracellular Action of Matrix Metalloproteinase-2 Accounts for Acute Myocardial Ischemia and Reperfusion Injury by Wenjie Wang, Costas J. Schulze, Wilma.
Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1 by Ilka Ott, Martin.
Activation of factor XI by products of prothrombin activation
Prostaglandin E2 Protects the Heart From Ischemia-Reperfusion Injury via Its Receptor Subtype EP4 by Chun-Yang Xiao, Koh-ichi Yuhki, Akiyoshi Hara, Takayuki.
Central role of Sp1-regulated CD39 in hypoxia/ischemia protection
Tissue-Specific Expression of Functional Platelet Factor XI Is Independent of Plasma Factor XI Expression by Chang-jun Hu, Frank A. Baglia, David C.B.
Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury by Shahrouz Ghafoory, Rohan Varshney, Tyler Robison, Karim Kouzbari,
Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI by Erik I. Tucker, Ulla M. Marzec, Tara C.
PRT , a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model by Michael P. Reilly, Uma Sinha,
Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases.
The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated.
by Manuel Yepes, Maria Sandkvist, Mike K. K. Wong, Timothy A
by Rafijul Bari, Teresa Bell, Wai-Hang Leung, Queenie P
Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS)‏ by David T. Teachey, Dana A. Obzut, Kelly Axsom,
Annexin A2 tetramer activates human and murine macrophages through TLR4 by Jennifer F. A. Swisher, Nicholas Burton, Silvia M. Bacot, Stefanie N. Vogel,
by Zhengyan Wang, Tina M. Leisner, and Leslie V. Parise
Emergence of muscle and neural hematopoiesis in humans
Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells by Christian P. Kalberer, Uwe Siegler, and Aleksandra Wodnar-Filipowicz.
Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes by James C. Zimring,
The tyrosine phosphatase SHP-1 dampens murine Th17 development
by Simon F. De Meyer, Alexander S. Savchenko, Michael S
Red pulp macrophages in the human spleen are a distinct cell population with a unique expression of Fc-γ receptors by Sietse Q. Nagelkerke, Christine W.
by Wu-Guo Deng, Ying Zhu, and Kenneth K. Wu
by Éric Aubin, Réal Lemieux, and Renée Bazin
by Parisa Asvadi, Zohra Ahmadi, and Beng H. Chong
Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of.
Apoptotic Vascular Endothelial Cells Become Procoagulant
by Jun Yuan, David B. Lovejoy, and Des R. Richardson
Vascular endothelial growth factor stimulates protein kinase CβII expression in chronic lymphocytic leukemia cells by Simon T. Abrams, Benjamin R. B. Brown,
Combined PLX3397 and PTX treatment inhibits metastasis in a CD8-dependent manner. Combined PLX3397 and PTX treatment inhibits metastasis in a CD8-dependent.
Interaction of kindlin-3 and β2-integrins differentially regulates neutrophil recruitment and NET release in mice by Zhen Xu, Jiayi Cai, Juan Gao, Gilbert.
by Yuko Kimura, Takashi Miwa, Lin Zhou, and Wen-Chao Song
Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo by Rukhsana.
Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function by Vânia Coelho, Sergey Krysov, Andrew.
by Ulrike Schleicher, Andrea Hesse, and Christian Bogdan
Volume 115, Issue 1, Pages (July 1998)
Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15 by Lazar.
Dasatinib enhances megakaryocyte differentiation but inhibits platelet formation by Alexandra Mazharian, Cedric Ghevaert, Lin Zhang, Steffen Massberg,
Effects of SC144 on in vivo ovarian tumor.
Elevated ecto-5′-nucleotidase: a missing pathogenic factor and new therapeutic target for sickle cell disease by Hong Liu, Morayo Adebiyi, Rong Rong Liu,
Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis by Manasa K. Nayak, Nirav Dhanesha,
An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth by Toshihiko Tanno, Peng Zhang,
Enhancing functional platelet release in vivo from in vitro–grown megakaryocytes using small molecule inhibitors by Danuta Jarocha, Karen K. Vo, Randolph.
A fully recombinant human IgG1 Fc multimer (GL-2045) inhibits complement-mediated cytotoxicity and induces iC3b by Hua Zhou, Henrik Olsen, Edward So, Emmanuel.
Proteasome Inhibition Attenuates Infarct Size and Preserves Cardiac Function in a Murine Model of Myocardial Ischemia-Reperfusion Injury  William E. Stansfield,
Stefano Toldo et al. BTS 2017;2:
Inter-α inhibitor proteins maintain neutrophils in a resting state by regulating shape and reducing ROS production by Soe Soe Htwe, Hidenori Wake, Keyue.
Accelerated, but not conventional, radiotherapy of murine B-cell lymphoma induces potent T cell–mediated remissions by Suparna Dutt, Michelle B. Atallah,
Cytotoxic therapy induces CSF1-dependent macrophage recruitment.
by Cheryl L. Maier, Amanda Mener, Seema R. Patel, Ryan P
Antiangiogenic effects of decorin restored by unfractionated, low molecular weight, and nonanticoagulant heparins by Amy K. L. Chui, Tilini N. Gunatillake,
by Seema R. Patel, Ashley Bennett, Kathryn Girard-Pierce, Cheryl L
Exosomal regulation of lymphocyte homing to the gut
Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm by Hew Yeng Lai, Stefan A. Brooks,
2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopenia by Elizabeth Tkaczynski, Abinaya Arulselvan, John Tkaczynski,
The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency by Pradeep Bangalore-Prakash, Laura.
Interleukin-2–inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells by Sami Mamand, Matthew Carr,
TREM-like transcript 1: a more sensitive marker of platelet activation than P-selectin in humans and mice by Christopher W. Smith, Zaher Raslan, Lola Parfitt,
Pathogenicity and Epitope Characteristics of Anti-Desmoglein-1 from Pemphigus Foliaceus Patients Expressing Only IgG1 Autoantibodies  Mary K. Hacker-foegen,
Inhibition of contact-mediated activation of factor XI protects baboons against S aureus–induced organ damage and death by Robert Silasi, Ravi Shankar.
Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura by Liang Zheng, Yingying.
Interactions of neutrophil-derived OSM with gp130-containing receptors on endothelial cells enhance P-selectin–dependent rolling in mouse postcapillary.
H. pylori induces STAT3 nuclear translocation and transcriptional activation in a CagA-dependent manner. H. pylori induces STAT3 nuclear translocation.
Brain ischemic tolerance model using mouse MCAO
by Gonghua Huang, Yanyan Wang, Peter Vogel, and Hongbo Chi
HMQ1611 inhibited breast tumor growth in mice.
Presentation transcript:

Factor XI contributes to myocardial ischemia-reperfusion injury in mice by Christina U. Lorentz, Norah G. Verbout, Zhiping Cao, Lijuan Liu, Monica T. Hinds, Owen J. T. McCarty, Ivan Ivanov, Erik I. Tucker, David Gailani, and András Gruber BloodAdv Volume 2(2):85-88 January 23, 2018 © 2018 by The American Society of Hematology

Effects of anti-FXI IgG 14E11 on FXII activation by FXIa and FXI autoactivation, in vitro. Effects of anti-FXI IgG 14E11 on FXII activation by FXIa and FXI autoactivation, in vitro. The 14E11 antibody binds the A2 domain of mammalian FXI and inhibits its activation by FXIIa. Experiments were performed to elucidate additional effects of 14E11 on the FXII-FXI axis. (A) FXIIa activity is shown as a function of 14E11 antibody concentration. A mixture of purified human FXII and FXIa was incubated with 14E11, and FXIIa amidolytic activity was measured and expressed as the concentration of FXIIa generated in the reaction mixture. The antibody inhibits activation of purified human FXII by purified human FXIa in a concentration-dependent manner, in vitro. (B) FXI autoactivation is shown as a function of 14E11 antibody concentration. Purified human FXI was mixed with purified leukocyte-derived DNA in the presence of various concentrations of 14E11. FXIa amidolytic activity was measured and expressed as the concentration of FXIa that was generated in the reaction mixture. The antibody inhibits the DNA-induced autoactivation of purified human FXI in a concentration-dependent manner, in vitro. Christina U. Lorentz et al. Blood Adv 2018;2:85-88 © 2018 by The American Society of Hematology

Effects of anti-FXI IgG 14E11 in the murine myocardial ischemia-reperfusion model. Effects of anti-FXI IgG 14E11 in the murine myocardial ischemia-reperfusion model. (A) Representative sections of mouse hearts from animals treated during ischemia with vehicle (top) or 14E11 (bottom), followed by 2-hour reperfusion. The images on the left show the AAR of ischemia as areas devoid of fluorescent microspheres, whereas the TTC-stained images at right show infarcted tissue (paler areas in which the TTC stain is not taken up). (B) AARs for each group were calculated and are presented as percentages of total ventricular volume. (C) Treatment with 14E11 reduced the infarct size (percentage of AAR undergoing infarction) after regional myocardial ischemia-reperfusion. Data are shown as the means ± SEM of infarct size normalized to the AAR (n = 10 mice/group; *P ≤ .0001, 14E11 vs vehicle). Christina U. Lorentz et al. Blood Adv 2018;2:85-88 © 2018 by The American Society of Hematology